Skylight Investment

B9 is an on-demand income streaming platform assisting employees to gain control over their finances, including their ability to receive earned paycheck without having to wait until payday. It provides their customers with suite of financial wellness benefits, and access to modern banking.

Cardea Bio, Inc. is a biotechnology company based in San Diego, California, specializing in bioelectronics and graphene-based digital biosensor technology. Founded in 2013, the company develops products that facilitate precision healthcare by enhancing the ease, speed, and cost-effectiveness of diagnostics. Its key offerings include AGILE R100, an innovative assay for small molecule drug discovery, and AGILE R200, an automated high-throughput screening solution. Cardea's biosensors utilize biocompatible graphene to transform biological signals into digital data, enabling real-time analysis of biomolecules. This technology supports applications in small molecule validation, antibody characterization, and biomolecular analysis, serving the life sciences and healthcare sectors. The company also sells its products online, contributing to advancements in research and diagnostics.

Butlr Technologies Inc. develops a wireless sensor system that captures and transmits real-time data on human movement and behavior in various environments, particularly in retail and hospitality. Founded in 2019 and based in Burlingame, California, Butlr's technology combines proprietary hardware with advanced artificial intelligence to analyze location and duration data, translating it into insights about consumer preferences and behaviors. The company's low-cost thermal imaging system gained attention during the coronavirus pandemic as a tool to protect the health of employees and customers. Unlike traditional cameras, Butlr's sensors detect unique biometric heat signatures, allowing for privacy-preserving monitoring while enabling businesses to optimize their spaces. This technology has broader implications, with a vision for responsive architecture that adapts environments based on real-time data, potentially enhancing urban infrastructure by predicting and responding to dynamic conditions such as pedestrian traffic and weather changes.

Tivic Health is a bioelectronic therapeutics company. We translate neuroscience into consumer-friendly medical devices, expanding the role of bioelectronic therapies in the healthcare ecosystem. Their first innovation, ClearUP™ Sinus Pain Relief, delivers temporary relief of sinus pain. It’s a small handheld device that’s easy to use, re-usable, and clinically proven. The company received FDA Clearance January 2, 2019 and will be shipping product in September 2019.

Valitor, Inc. is a biotechnology company based in Berkeley, California, founded in 2010. The company specializes in developing advanced, protein-based drugs and has established pipelines targeting oncology, dermatology, ophthalmology, and orthopedics. Valitor employs novel methods to modify therapeutic proteins, enhancing their pharmacokinetics, target specificity, and bioactivity. This innovative technology platform aims to improve the pharmacological properties of both existing and emerging protein drugs, allowing for more effective treatment strategies for various diseases. By focusing on targeted therapeutic delivery, Valitor seeks to optimize patient outcomes through its next-generation drug development initiatives.

Our Mission: Let artificial intelligence penetrate to every industry Our Vision: Short-Term: Build an authoritative, reliable, and trustworthy trading platform to link artificial intelligence services by docking buyers and sellers globally. Mid-Term: Empower growth of Chinese AI industry and contribute to the global development of artificial intelligence. Long-Term: Create a global artificial intelligence ecosystem which established, owned, and shared by every people

Tivic Health is a bioelectronic therapeutics company. We translate neuroscience into consumer-friendly medical devices, expanding the role of bioelectronic therapies in the healthcare ecosystem. Their first innovation, ClearUP™ Sinus Pain Relief, delivers temporary relief of sinus pain. It’s a small handheld device that’s easy to use, re-usable, and clinically proven. The company received FDA Clearance January 2, 2019 and will be shipping product in September 2019.